Ding Q - Search Results

1

Resin-capture and release strategy toward combinatorial libraries of 2,6,9-substituted purines.

Ding S, Gray NS, Ding Q, Wu X, Schultz PG. Ding S, et al. Among authors: ding q. J Comb Chem. 2002 Mar-Apr;4(2):183-6. doi: 10.1021/cc010080i. J Comb Chem. 2002. PMID: 11886295

2

A combinatorial scaffold approach toward kinase-directed heterocycle libraries.

Ding S, Gray NS, Wu X, Ding Q, Schultz PG. Ding S, et al. Among authors: ding q. J Am Chem Soc. 2002 Feb 27;124(8):1594-6. doi: 10.1021/ja0170302. J Am Chem Soc. 2002. PMID: 11853431

3

A small molecule with osteogenesis-inducing activity in multipotent mesenchymal progenitor cells.

Wu X, Ding S, Ding Q, Gray NS, Schultz PG. Wu X, et al. Among authors: ding q, ding s. J Am Chem Soc. 2002 Dec 11;124(49):14520-1. doi: 10.1021/ja0283908. J Am Chem Soc. 2002. PMID: 12465946

4

A concise and traceless linker strategy toward combinatorial libraries of 2,6,9-substituted purines.

Ding S, Gray NS, Ding Q, Schultz PG. Ding S, et al. Among authors: ding q. J Org Chem. 2001 Nov 30;66(24):8273-6. doi: 10.1021/jo016010f. J Org Chem. 2001. PMID: 11722241 No abstract available.

5

Small molecules that induce cardiomyogenesis in embryonic stem cells.

Wu X, Ding S, Ding Q, Gray NS, Schultz PG. Wu X, et al. Among authors: ding q, ding s. J Am Chem Soc. 2004 Feb 18;126(6):1590-1. doi: 10.1021/ja038950i. J Am Chem Soc. 2004. PMID: 14871063

6

Rearrangement of N,N-di-tert-butoxycarbonylpyridin-4-amines and formation of polyfunctional pyridines.

Liu Y, Ding Q, Wu X. Liu Y, et al. Among authors: ding q. J Org Chem. 2008 Aug 1;73(15):6025-8. doi: 10.1021/jo800854d. Epub 2008 Jul 9. J Org Chem. 2008. PMID: 18610981

7

Discovery of EGFR selective 4,6-disubstituted pyrimidines from a combinatorial kinase-directed heterocycle library.

Zhang Q, Liu Y, Gao F, Ding Q, Cho C, Hur W, Jin Y, Uno T, Joazeiro CA, Gray N. Zhang Q, et al. Among authors: ding q. J Am Chem Soc. 2006 Feb 22;128(7):2182-3. doi: 10.1021/ja0567485. J Am Chem Soc. 2006. PMID: 16478150

8

A type-II kinase inhibitor capable of inhibiting the T315I "gatekeeper" mutant of Bcr-Abl.

Choi HG, Ren P, Adrian F, Sun F, Lee HS, Wang X, Ding Q, Zhang G, Xie Y, Zhang J, Liu Y, Tuntland T, Warmuth M, Manley PW, Mestan J, Gray NS, Sim T. Choi HG, et al. Among authors: ding q. J Med Chem. 2010 Aug 12;53(15):5439-48. doi: 10.1021/jm901808w. J Med Chem. 2010. PMID: 20604564 Free PMC article.

9

Expanding the diversity of allosteric bcr-abl inhibitors.

Deng X, Okram B, Ding Q, Zhang J, Choi Y, Adrián FJ, Wojciechowski A, Zhang G, Che J, Bursulaya B, Cowan-Jacob SW, Rummel G, Sim T, Gray NS. Deng X, et al. Among authors: ding q. J Med Chem. 2010 Oct 14;53(19):6934-46. doi: 10.1021/jm100555f. J Med Chem. 2010. PMID: 20828158 Free PMC article.

10

The Dawn of Allosteric BCR-ABL1 Drugs: From a Phenotypic Screening Hit to an Approved Drug.

Teng M, Luskin MR, Cowan-Jacob SW, Ding Q, Fabbro D, Gray NS. Teng M, et al. Among authors: ding q. J Med Chem. 2022 Jun 9;65(11):7581-7594. doi: 10.1021/acs.jmedchem.2c00373. Epub 2022 May 24. J Med Chem. 2022. PMID: 35609336 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,656 results

Search Page

Filters